手性尼莫地平绝对构型的确定和关联

doi:10.3866/PKU.WHXB201606132

物理化学学报 >> 2016, Vol. 32 >> Issue (9): 2241-2254.doi: 10.3866/PKU.WHXB201606132

手性尼莫地平绝对构型的确定和关联

郭栋¹,宋嘉熙²,李丹¹,陈嘉媚²,林丽榕¹,鲁统部^2,*(),章慧^1,*()

¹ 厦门大学化学化工学院化学系,福建厦门361005
² 中山大学化学与化学工程学院,广州510275

收稿日期:2016-05-12 发布日期:2016-09-08
通讯作者: 鲁统部,章慧 E-mail:lutongbu@mail.sysu.edu.cn;huizhang@xmu.edu.cn
基金资助:
国家自然科学基金(21273175);国家自然科学基金(21331007);国家自然科学基金(21271150);广东省自然科学基金(S2012030006240)

Determination and Correlation of the Absolute Configurations of Chiral Nimodipine

Dong GUO¹,Jia-Xi SONG²,Dan LI¹,Jia-Mei CHEN²,Li-Rong LIN¹,Tong-Bu LU^2,*(),Hui ZHANG^1,*()

¹ Department of Chemistry, College of Chemistry and Chemical Engineering, Xiamen University, Xiamen 361005, Fujian Province, P. R. China
² School of Chemistry and Chemical Engineering, Sun Yat-Sen University, Guangzhou 510275, P. R. China

Received:2016-05-12 Published:2016-09-08
Contact: Tong-Bu LU,Hui ZHANG E-mail:lutongbu@mail.sysu.edu.cn;huizhang@xmu.edu.cn
Supported by:
National Natural Science Foundation of China(21273175);National Natural Science Foundation of China(21331007);National Natural Science Foundation of China(21271150);Natural Science Foundation of Guangdong Province, China(S2012030006240)

摘要/Abstract

摘要：

概述了手性1, 4-二氢吡啶类（1, 4-DHPs）钙拮抗剂的立体化学结构及其药效与绝对构型的关系，以及尼莫地平（nimodipine）的多晶型现象。采用单晶X射线衍射与固体和溶液圆二色（ECD）光谱直接关联的方法，对自发拆分获得的一对尼莫地平外消旋聚集体进行了绝对构型确定，首次获得了手性1, 4-DHPs类化合物的固体和溶液ECD光谱图。本方法对确认有机小分子的绝对构型，以及关联系列手性1, 4-DHP衍生物的绝对构型具有重要参考价值，同时提供了有别于常规非手性方法鉴别优势手性药物晶型的有效手段。

关键词: 1, 4-二氢吡啶, 绝对构型关联, 尼莫地平, 多晶型, 原料药(API), 自发拆分, 电子圆二色

Abstract:

The stereochemical structures and absolute configuration-pharmacological activity relationship of chiral l, 4-dihydropyridines (1, 4-DHPs) calcium channel drugs were summarized. Additionally, the polymorphic forms of nimodipine were investigated. The absolute configurations of a pair of chiral nimodipines as a conglomerate prepared by spontaneous resolution under chiral crystallization were confirmed via X-ray crystallographic analysis directly correlated with their solid-state and solution electronic circular dichroism (ECD) spectra. The solid-state and solution ECD spectra of chiral l, 4-DHPs were obtained for the first time. This comprehensive method can be used to determine the absolute configurations of small organic molecules. Furthermore, it can be extended to correlate the absolute configurations of other series of chiral l, 4-DHP derivatives in the future. We also presented some effective techniques to distinguish polymorphs of chiral active pharmaceutical ingredients (APIs), which differ from the non-chiral conventional methods, to allow qualitative identification of different chiral crystalline states of APIs in pharmaceutical preparations.

Key words: 1, 4-Dihydropyridine, Absolute configuration correlation, Nimodipine, Polymorphism, Active pharmaceutical ingredient, Spontaneous resolution, Electronic circular dichroism

郭栋,宋嘉熙,李丹,陈嘉媚,林丽榕,鲁统部,章慧. 手性尼莫地平绝对构型的确定和关联[J]. 物理化学学报, 2016, 32(9): 2241-2254.

Dong GUO,Jia-Xi SONG,Dan LI,Jia-Mei CHEN,Li-Rong LIN,Tong-Bu LU,Hui ZHANG. Determination and Correlation of the Absolute Configurations of Chiral Nimodipine[J]. Acta Phys. -Chim. Sin., 2016, 32(9): 2241-2254.

链接本文: https://www.whxb.pku.edu.cn/CN/10.3866/PKU.WHXB201606132

https://www.whxb.pku.edu.cn/CN/Y2016/V32/I9/2241

参考文献

1	Hantzsch A. Chem. Ber 1881, 14 (2), 1637.
2	Goldmann S. ; Stoltefuss J. Angew. Chem. Int. Edit. Engl 1991, 30 (12), 1559- 1578.
3	Triggle D. J. Cell. Mol. Neurobiol 2003, 23 (3), 293.
4	Tamazawa K. ; Arima H. ; Kojima T. ; Isomura Y. ; Okada M. ; Fujita S. ; Furuya T. ; Takenaka T. ; Inagaki O. ; Terai M. J. Med. Chem 1986, 29 (12), 2504.
5	Marciniak G. ; Delgado A. ; Leclerc G. ; Velly J. ; Decker N. ; Schwartz J. J. Med. Chem 1989, 32 (6), 1402.
6	Cai D. S. Shanghai Med. Pharma. J. 2005, 26 (9), 421.
6	蔡德山. 上海医药, 2005, 26 (9), 421.
7	Clayden J. ; Moran W. J. ; LaPlante S. R. Angew. Chem. Int. Edit 2009, 48 (35), 6398.
8	Barbato F. ; Quaglia F. ; Quercia M. T. ; La Rotonda M.I. Helv. Chim. Acta 2000, 83 (4), 767.
9	Inotsume N. ; Nakano M. J. Biochem. Biophys. Methods 2002, 54 (1-3), 255.
10	Guo P. C. ; Huang H. L. Prog. Mod. Biomed 2009, 9 (1), 181.
10	郭鹏程; 黄红林. 现代生物医学进展, 2009, 9 (1), 181.
11	Lu D. Q. ; Chang Y. J. ; Ling X. Q. ; Chen J. ; Zhao P. ; Wang J. L. Chem. Ind. Eng. Prog 2010, 29 (12), 2351.
11	卢定强; 常亚军; 凌岫泉; 陈佳; 赵鹏; 王加力. 化工进展, 2010, 29 (12), 2351.
12	Kawabata K. ; Samata N. ; Urasaki Y. ; Fukazawa I. ; Uchida N. ; Uchida E. ; Yasuhara H. J. Chromatogr. B 2007, 852 (1-2), 389.
13	Cai, D. S. http://www.sinohealth.com/2015/0116/16556.shtml(accessed Mar. 31, 2016).
14	Young, J.W. Methods and Compositions for TreatingHypertension, Angina and Other Disorders Using Optically Pure(-) Amlodipine. WO93/10779, 1993-06-10.
15	Spargo, P. L. Separation of the Enantiomers of Amlodipine viaTheir Diastereomeric Tartrates. WO1995025722A1, 1995-03-06.
16	Gharpure, M. M.; Bhawal, B. M.; Ranade, P. V.; Deshmukh, R.D.; Mehta, S. R. Process for Enantiomer of Amlodipine in HighOptical Purity. EP1802576B1, 2008-06-25.
17	Gotrane D. M. ; Deshmukh R. D. ; Ranade P. V. ; Sonawane S.P. ; Bhawal B. M. ; Gharpure M. M. ; Gurjar M. K. Org. Process Res. Dev 2010, 14 (3), 640.
18	Arrowsmith J. E. ; Campbell S. F. ; Cross P. E. ; Stubbs J. K. ; Burges R. A. ; Gardiner D. G. ; Blackburnt K. J. J. Med. Chem 1986, 29 (9), 1696.
19	Arrowsmith, J. E. Preparation of R-and S-Amlodipine.EP0331315A2, 1989-02-16.
20	Goldmann S. ; Stoltefuss J. ; Born L. J. Med. Chem 1992, 35 (18), 3341.
21	Du G. H. ; Lv Y. Chin. Pharma. J 2010, 45 (1), 5.
21	杜冠华; 吕扬. 中国药学杂志, 2010, 45 (1), 5.
22	Lv Y. ; Du G. H. Polymorphism of Drug Beijing: People's MedicalPublishing House, 2009.
22	吕扬; 杜冠华. 晶型药物, 北京: 人民卫生出版社, 2009.
23	Xing, C.; Sun, J. L.; Yang, S. Y.; Lv, Y.; Du, G. H.; Liu, G. Z.; Xie, Y. C.; Wang, J. Study on the State of Polymorphs in theDomestic Solid Pharmaceutical Preparations of Nimodipine. InThe Conference on The Third China Polymorphism of Drug's Research Technology; 2011; pp 75-81.
23	刑逞,孙加琳,杨世颖,吕扬,杜冠华,刘广桢,谢元超,王杰.国产尼莫地平固体制剂的晶型现状研究.第三届中国晶型药物研发技术学术研讨会论文集, 2011: 75-81.
24	Yang S. Y. ; Xing C. ; Zhang L. ; Sun J. L. ; Du G. H. ; Lv Y. Herald Med 2015, 34 (7), 930.
24	杨世颖; 邢逞; 张丽; 孙加琳; 杜冠华; 吕扬. 医药导报, 2015, 34 (7), 930.
25	Burger A. ; Rollinger J. M. ; Brüggeller P. J. Pharm. Sci 1997, 86 (6), 674.
26	Frelek J. ; Górecki M. ; ?aszcz M. ; Suszczyńska A. ; Vass E. ; Szczepek W. J. Chem. Commun 2012, 48 (43), 5295d.
27	Górecki, M.; Frelek, J.; Szczepek, W. J. Circular Dichroic Studyon Polymorphism Phenomenon of Chiral Active PharmaceuticalIngredients (APIs). In 25th International Symposium on Chirality; Shanghai, 2013; Poster.
28	Frelek J. ; Górecki M. ; Dziedzic A. ; Jab?ońska E. ; Kamieński B. ; Wojcieszczyk R. K. ; Luboradzki R. ; Szczepek W. J. J. Pharm. Sci 2015, 104 (5), 1650.
29	Wang S. D. ; Herbette L. G. ; Rhodes D. G. Acta Cryst 1989.
30	Langs D. A. ; Strong P. D. ; Triggle D. J. J. Comput.-Aided Mol. Des 1990, 4 (3), 215.
31	Grunenberg A. ; Keil B. ; Henck J. O. Int. J.Pharm 1995, 118 (1), 11.
32	Wang J. ; Zhang R. H. ; Sun S. Y. Acta Pharm. Sin 1995, 30 (6), 443.
32	王晋; 张汝华; 孙淑英. 药学学报, 1995, 30 (6), 443.
33	Docoslis A. ; Huszarik K. L. ; Papageorgiou G. Z. ; Bikiaris D. ; Stergiou A. ; Georgarakis E. AAPS J 2006, 9 (3), 361.
34	Wang Y. ; Li Y. ; Wu S. G. ; Gong J. B. ; Wang Y. L. ; Wei Z. P. West China J.Pharm. Sci 2014, 29 (5), 491.
34	王玥; 李益; 吴送姑; 龚俊波; 王永莉; 魏振平. 华西药学杂志, 2014, 29 (5), 491.
35	Boatto G. ; Nieddu M. ; Faedda M. V. ; Caprariis P. Chirality 2003, 15 (6), 494.
36	Wanner-Olsen H. ; Gaarsk?r F. B. ; Mikkelsen E. O. ; Jakobsen P. ; Voldby B. Chirality 2000, 12 (9), 660.
37	De Beun R. ; Schneider R. ; Klein A. ; Lohmann A. ; De Vry J. Alcohol 1996, 13 (3), 263.
38	Fisher C. ; Sch?nberger F. ; Mück W. ; Heuck K. ; Eichelbaum M. J. Pharm. Sci 1993, 82 (3), 244.
39	Schaechtele C. ; Wagner B. ; Marme D. Arch Pharm 1987, 335 (3), 340.
40	Towart R. ; Wehinger E. ; Meyer H. ; Kazda S. Arzneim.-Forsch 1982, 32 (4), 338.
41	Ding L. ; Lin L. R. ; Liu C. Y. ; Li H. K. ; Qin A. J. ; Liu Y. ; Song L. ; Zhang H. ; Tang B. Z. ; Zhao Y. F. New J.Chem 2011, 35 (9), 1781.
42	Zhang H. ; Yan J. X. ; Wu S. T. ; Li D. ; Wan S. G. ; Ding L. ; Lin L. R. Acta Phys.-Chim. Sin 2013, 29 (12), 2481.
42	章慧; 颜建新; 吴舒婷; 李丹; 万仕刚; 丁雷; 林丽榕. 物理化学学报, 2013, 29 (12), 2481.
43	Li, D.; Guo, D.; Song, J. X.; Shen, D. D.; Chen, J. M.; Lu, T. B.; Zhang, H. Fingerprint Features in the Characterization of ChiralActive Pharmaceutical Ingredients——Integrated Solid-stateChiroptical Spectroscopy. In The Sixth Symposium on Molecules Chirality in China. Wuhan, 2014; pp 91-96.
43	李丹,郭栋,宋嘉熙,沈大冬,陈嘉媚,鲁统部,章慧.晶型手性药物表征的指纹特征——集成的固体手性光谱.中国化学会第六届全国分子手性学术研讨会,武汉, 2014: 91-96.
44	Wang, Y. K.; Jia, J.; Feng, L. X.; Liu, L. L.; Zhao, X.; Zhang, H.The Analysis for the Optical Active Origin of Nimodipine andIts Solution Conformations. In The Sixth Symposium on Molecules Chirality in China. Wuhan, 2014; pp 91-96.
44	王越奎,贾杰,冯丽霞,刘林林,赵霞,章慧.尼莫地平的光学活性起源与溶液构象分析.中国化学会第六届全国分子手性学术研讨会,武汉, 2014: 29-31.
45	Joshi, R. R.; Joshi, R. A.; Karade, N. B.; Gurjar, M. K. Processfor Preparation of Chiral Amlodipine Salts. WO2005/049571A1, 2004-10-19.
46	Sheldrick, G. M. SHELX97 (SHELXS-97 and SHELXL-97), Program for Crystal Structure Analyses; University ofGottingen: Gottingen, Germany, 1997.
47	Tokuma Y. ; Noguchi H. J. Chromatogr. A 1995, 694 (1), 181.
48	Shibanuma T. ; Iwanani M. ; Okuda K. ; Takenaka T. ; Murakami M. Chem. Pharm. Bull 1980, 28 (9), 2809d.
49	Kajino M. ; Wada Y. ; Nagai Y. ; Nagaoka A. ; Meguro K. Chem. Pharm. Bull 1989, 37 (8), 2225.
50	Eltze M. ; Boer R. ; Sanders K. H. ; Boss H. ; Ulrich W. R. ; Flockerzi D. Chirality 1990, 2 (4), 233.
51	Ashimori A. ; Uchida T. ; Ohtaki Y. ; Tanaka M. ; Ohe K. ; Fukaya C. ; Watanabe M. ; Kagitani M. ; Yokoyama K. Chem. Pharm. Bull 1991, 39 (1), 108.
52	Zhang B. L. ; He W. ; Shi X. ; Huan M. L. ; Huang Q. J. ; Zhou S. Y. Bioorg. Med. Chem. Lett 2010, 41 (39), 805.
53	Lamm B. ; Simonssona R. ; Sundellb S. Tetrahedron Lett 1989, 30 (46), 6423.
54	Ikawa, H.; Kadoiri, A.; Sekine, Y. Optical Active l, 4-Dihydropyridine Derivatives. EP403957. 1990-12-27.
55	Holdgrün X. K. ; Sih C. J. Tetrahedron Lett 1991, 32 (29), 3465.
56	Flack H. D. Helv. Chim. Acta 2003, 86 (4), 905.
57	Müller, U. Inorganic Structural Chemistry, 2nd ed.; JohnWiley & Sons, Ltd.:West Sussex, 2007; p 83.
58	Pérez-García L. ; Amabilino D. B. Chem. Soc. Rev 2002, 31 (6), 342.
59	Dryzun C. ; Avnir D. Chem. Commun 2012, 48 (47), 5874d.
60	Pidcock E. Chem. Commun 2005.
61	Matsuura T. ; Koshima H.J. Photochem. Photobiol. C 2005, 6 (1), 7.
62	McLaughlin D. T. ; Nguyen T. P. T. ; Mengnjo L. ; Bian C. ; Leung Y. H. ; Goodfellow E. ; Ramrup P. ; Woo S. ; Cuccia L. A. Cryst. Growth Des 2014, 14 (3), 1067.
63	Eliel, E. L.; Wilen, S. H.; Mander, L. N. Stereochemistry of Organic Compounds; John Wiley & Sons: New York, 2001; chapters 6-7.
64	Lennartson A. ; Vestergren M. ; H?kansson M. Chem. Eur. J 2005, 11 (6), 1757.
65	Dai J. Q. ; Krohn K. ; Fl?rke U. ; Pescitelli G. ; Kerti G. ; Papp T. ; K?vér K. E. ; Bényei A. C. ; Draeger S. ; Schulz B. ; Kurtán T. Eur. J.Org. Chem 2010.

[1]	曹石,曾丽丽,谢菁,万仕刚,李丹,章慧. 席夫碱Cu(Ⅱ)络合物的超分子螺旋手性及其手性光谱[J]. 物理化学学报, 2017, 33(12): 2480 -2490 .
[2]	章慧,曾丽丽,王越奎,曹石,郭栋,李丹,方雪明,林丽榕. 手性Salen-Ni(Ⅱ)络合物的ECD光谱及其绝对构型关联:可见区第一ECD吸收带的指纹作用[J]. 物理化学学报, 2015, 31(12): 2229 -2250 .

手性尼莫地平绝对构型的确定和关联

Determination and Correlation of the Absolute Configurations of Chiral Nimodipine

RichHTML

PDF

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 2

Metrics

推荐阅读 0